0001567619-22-001375.txt : 20220120
0001567619-22-001375.hdr.sgml : 20220120
20220120171314
ACCESSION NUMBER: 0001567619-22-001375
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220118
FILED AS OF DATE: 20220120
DATE AS OF CHANGE: 20220120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loewy Caroline M
CENTRAL INDEX KEY: 0001367451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32001
FILM NUMBER: 22543132
MAIL ADDRESS:
STREET 1: 300 ELLIOTT AVE WEST
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98119-4114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptose Biosciences Inc.
CENTRAL INDEX KEY: 0000882361
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 251 CONSUMERS ROAD
STREET 2: SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
BUSINESS PHONE: 647-479-9828
MAIL ADDRESS:
STREET 1: 251 CONSUMERS ROAD
STREET 2: SUITE 1105
CITY: TORONTO
STATE: A6
ZIP: M2J 4R3
FORMER COMPANY:
FORMER CONFORMED NAME: Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.)
DATE OF NAME CHANGE: 20140905
FORMER COMPANY:
FORMER CONFORMED NAME: LORUS THERAPEUTICS INC
DATE OF NAME CHANGE: 19990308
FORMER COMPANY:
FORMER CONFORMED NAME: IMUTEC PHARMA INC
DATE OF NAME CHANGE: 19970113
4
1
doc1.xml
FORM 4
X0306
4
2022-01-18
0
0000882361
Aptose Biosciences Inc.
APTO
0001367451
Loewy Caroline M
C/O APTOSE BIOSCIENCES
251 CONSUMERS ROAD, SUITE 1105
TORONTO
A6
M2J 4R3
ONTARIO, CANADA
1
0
0
0
Director Stock Option (Right to Buy)
1.34
2022-01-18
4
A
0
50000
0
A
2032-01-17
Common Shares
50000
50000
D
The options were granted on January 18, 2022, and vest as follows: 50% vest on January 18, 2023; 25% vest on January 18, 2024; and 25% vest on January 18, 2025.
/s/ Janet Clennett as attorney-in-fact for Caroline M. Loewy
2022-01-20